anthonyyazdaniml/gliner-biomed-balanced-curated-corpus huggingface dataset:
FIELD: medicine, endocrinology, phytotherapy, food industry. SUBSTANCE: invention relates to dry mixture prepared of vegetable medicinal raw. Proposed agent containing walnut and cultured grape leaves has wild strawberry leaves, goat&#39;s-rue (Galega) leaves and trefoil flowers taken at the definite ratio of components. Agent shows antianemic and antiinflammatory effect and can be used as the natural ecologically pure food addition as herb tea showing tonic property and for improvement of appetite and digestion. Agent can be used for prophylaxis and treatment of patients with diabetes mellitus. EFFECT: enhanced effectiveness of an agent. 1 cl, 3 ex
PURPOSE:To obtain an inhalant for the treatment and prevention of cardiac insufficiency, containing a specific dihydropyridine derivative or its salt as an active component and effective for lowering the left ventricular end diastolic pressure and pulmonary capillary pressure without largely depressing the systemic blood pressure or lowering the cardiac function. CONSTITUTION:This inhalant for the treatment and prevention of cardiac insufficiency contains a dihydropyridine derivative expressed by formula (R&lt;1&gt; to R&lt;3&gt; each is a lower alkyl; A is a 2-6C unsaturated chain hydrocarbon residue) or its salt as an active component. The compound of formula is especially preferably methyl 3-phenyl-2-propenyl-l,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3-5-dicarboxylate. The cardiac insufficiency is e.g. myocardial infarction, infectious endocarditis, pericardial tamponade, myocarditis, cardiac myopathy, heart valve disease, congenital heart disease, right ventricular myocardial infarction, brain embolism, pulmonary infarction, acute tricuspid incompetence, chronic left ventricular failure and chronic right ventricular failure. The daily dose of the compound of formula is preferably about 0.001-0.1mg per 1kg body weight.
PROBLEM TO BE SOLVED: To obtain a new compound useful for cosmetics excellent in pigmentation inhibitory effect and skin whitening effect as well as safety to the skin and preservability. SOLUTION: This new compound is expressed by the formula (R&lt;1&gt; -R&lt;4&gt; are each H or COR; R is a 1-20C alkyl), e.g. 1,3-bis(2,4-dihydroxyphenyl)propane. The compound of the formula is obtained by the following process: Dioscorea composita, a kind of plant belonging to Dioscoreaceae, is dried optionally, and, chopped optionally, and then brought into contact with an extractive solvent such as water or ethanol, and the resultant extract is subjected to refining and separation. The amount of the extractive solvent to be used is 100 pts.wt. based on 5-50 pts.wt. of the Dioscorea composita on a dry basis. The other objective cosmetic contains, as active ingredient, the compound of the formula at 0.0001-20wt.%, and can be prepared into the form of face lotion, milky lotion, cream, lipstick, foundation, pack, face wash, etc.
Disclosure herein is related to a telemedicine information system. The telemedicine information system includes a monitoring end which receives the physiological signals generated by one or more physiological sensors disposed at the client end over a network. The medical staff uses monitoring terminal device at the monitoring end. The monitoring terminal device is connected with a monitoring server for acquiring the physiological signals since the server periodically retrieves and records the signals generated by the client end&#39;s sensors. The signals will be converted to the meaningful information allowing the medical staff to monitor the remote client&#39;s physiological condition. The claimed system achieves an efficient remote medical process since the person at the monitoring end may anytime acknowledge the client&#39;s condition.
&lt;P&gt;PROBLEM TO BE SOLVED: To modulate effect of GDF-8 on a cell.  &lt;P&gt;SOLUTION: Provided is a use of a protein, GASP1, comprising at least one follistatin domain to modulate the level or activity of growth and differentiation factor-8 (GDF-8). More particularly, it relates to the use of GASP1 for treating disorders that are related to modulation of the level or activity of GDF-8. It is useful for treating muscular disorders and diseases, particularly those in which an increase in muscle tissue is therapeutically beneficial. It is also useful for treating diseases and disorders related to metabolism, adipose tissue, and bone degeneration.  &lt;P&gt;COPYRIGHT: (C)2010,JPO&amp;INPIT
PURPOSE:To provide the titled fine powder composed of regenerated protein fine powder containing an oily material dispersed and occluded therein as minute liquid droplets, containing an oily material having high functionality at a high rate, having excellent adhesivity, spreadability, masking power, dispersibility, etc., and useful for cosmetic, food, paint, etc. CONSTITUTION:An aqueous solution of a regenerated protein (e.g. silk fibroin, casein, collagen, etc.) having a concentration of 2-20(wt)%, especially 5-10% is mixed with an oily material or an oily material and an extender pigment and the resultant emulsified suspension liquid is subjected to isoelectric point coagulation, mixing with protein coagulant or agitation at high rate of shear strain (&gt;=50sec&lt;-1&gt;, especially &gt;=100sec&lt;-1&gt;) or their combination. The regenerated protein coagulated and precipitated by this procedure is washed with water, dried and pulverized to obtain the objective regenerated protein fine powder (preferably having maximum particle diameter of 3-30mu) containing an oily material and optionally an extender pigment dispersed and included in the powder as minute liquid droplets. The amount of the oily material included in the powder is 0.5-50%, preferably 1-20% of the powder and &lt;=25 times, especially &lt;=10 times weight of the regenerated protein.
Techniques disclosed herein relate to automatic pan-tilt-zoom adjustment to improve vital sign acquisition. In various embodiments, a vital sign acquisition camera (176) operable to pan, tilt, and zoom (&#34;PTZ&#34;) may capture (402) an image of a patient (100). The image may be analyzed (404) to detect a depicted position of the patient within an image coordinate space of the image. A desired position of the patient within the image coordinate space of the image may determined (406), and a difference in the image coordinate space between the depicted position and the desired position may be calculated (408). The difference may then be mapped (410) from the image coordinate space to a PTZ space. One or more PTZ parameters of the vital sign acquisition camera may be altered (412) based on the mapping. After altering the one or more PTZ parameters, the vital sign acquisition camera may acquire (414) one or more vital signs from the patient.
Pharmaceutical compositions which may be mixed with table salt to give a &#34;medicated&#34; product stable under conditions of high temperature and humidity consist of a salt of the antimalarials chloroquine or amodiaquine coated with a waxy or fatty substance having a melting point between 37 DEG  C. and 120 DEG  C., e.g. fatty alcohols or mixtures thereof, animal and vegetable fats and waxes, mineral waxes, long-chain fatty acids and their esters (including those with sorbitan and the mono- or di-polyoxyethylene esters), polyoxyethylene derivatives of partial esters of sorbitan, condensation products of fatty alcohols and ethylene oxide, esters of fatty alcohols with inorganic acids, fatty ethers, e.g. cetyl a -glyceryl ether, mineral and vegetable oils, optionally containing thickening agents or preservatives, hydrogenated vegetable or animal oils and natural or synthetic resins, e.g. shellac and cellulose acetate phthalate, such materials preferably having a melting point above 40 DEG  C.  Cetostearyl alcohol is stated to be particularly valuable.  Coating may be carried out by conventional procedures, e.g. addition of the coating material in solution in a volatile solvent to the drug and removal of the solvent by evaporation, spraying the drug with similar solutions whilst the drug is agitated or, when the melting point of the coating material is below about 120 DEG  C. by mixing the ingredients and heating to above the melting point of the waxy or fatty substance followed by cooling and comminution.
A method is provided for treating hormone-regulated tumors (for example, breast and prostatic tumors) in mammals, including humans, by administration of an antisense ODN which is complementary to a portion of the gene encoding IGFBP-5. Using the Shionogi tumor model in vitro and in vivo, the administration of such an ODN was shown to reduce proliferation of tumor cells, and also to delay the progression to androgen independence. Thus, treatment of prostate cancer in mammals, including humans, and delay of the progression of prostate tumors to androgen independence is accomplished by  administering to the mammal a therapeutically effective amount of an antisense oligodeoxynucleotide which is complementary to a portion of the nucleic acid sequence encoding IGFBP-5 and which hybridizes with such a sequence to inhibit expression of IGFBP-5. Specific antisense ODN&#39;s which are suitable for use in the method are GACCACGCTGATCACCAT (Seq. ID. No. 1), which is derived from the murine gene sequence, and CGCGGTGAGCAACACCAT (Seq. ID. No. 3) and AGGTCATGCAGCAGCCGC (Seq. ID No 4), which are derived from the human gene sequence.
PROBLEM TO BE SOLVED: To obtain the subject new compound having a strong antagonistic function to CRH receptor esp. CRH2 receptor and useful for treatment for melancholia, anxiety, anorexia nervosa, Alzheimer&#39;s disease or the like. SOLUTION: This compound is shown by the formula (X is S or O; A1 and A2 are each an aryl or heteroaryl; A3 is a benzene or pyridine ring; and R1 and R2 are each e.g. a lower alkyl, lower alkenyl), e.g. N,N-dimethyl-4-(4,5- diphenylthiazole-2-yl)aniline. A compound of the formula is obtained by reacting a halogenoketone derivative with a thioamide derivative in the equal molar ratio or slightly different molar ratio in an alcohol-based solvent such as isopropanol or methanol in the presence of a basic compound (e.g. calcium carbonate or potassium hydroxide) under heating, pref., under a heating reflux and, if necessary, removing any protecting group. When the protecting group of amino group is a benzyl group, it is removed by an acid treatment using dichloroacetic acid/methanol or the like.
A system is disclosed that includes a breathing apparatus, a display unit and a processing unit that is operatively connected to the display unit. The processing unit is configured to provide a graphical visualization on the display unit. The graphical visualization in turn includes a combination of a target indication for at least one ventilation related parameter of a ventilation strategy for a patient ventilated by the apparatus, and a reciprocating animation of the at least one ventilation related parameter relative the target indication. The target indication is for instance based on input of a user, such as an operator of the breathing apparatus. Alternatively, or in addition, it may be a default value stored on a memory unit being operatively connected to the processing unit. Alternatively, or in addition, the target indication is based on a measurement value of said patient&#39;s physiology or anatomy. In this manner, the system informs clinicians in a clear and easily understandable way how a current patient ventilation is related to a chosen ventilation strategy.
A method for planning the position of the maxilla in orthognathic surgery includes locating a maxillary position in which an extension of the occlusal plane passes along a tangent to the base of the skull, the bottom edge of the front incisors is situated 1-3 mm below the bottom edge of the upper lip, and the base of the nose is offset from a plane passing through the glabella by a distance equal to the distance from a plane Gb to a plane Tf. The extent to which the edge of a maxillary central incisor projects below the edge of the upper lip when the mouth is passively opened is determined (is - StS). In a bone tissue imaging mode, the tilt of the head is determined in a three-dimensional model of the head seen in a lateral view. Then, in a soft tissue mode, the planes Ro, Tf, Gb and Sn are established. In a bone structure mode, the occlusal plane OP is drawn. The profile depth deficiency PD&#39; is calculated. A point is&#39; is marked which represents the desired position of the edge of the maxillary central incisor relative to is and PD&#39;. A plane OP&#39; is drawn from the point is&#39; and parameters are obtained for determining the optimal post-surgical position of the maxilla. The invention allows more efficient location of an optimal post-surgical position.
PURPOSE:To obtain a hair-dressing base exhibiting high water-solubility, excellent detergency and high hair-setting power and free from stickiness by using a large amount of (meth)acrylic acid and polymerizing the acid in combination with a (meth)acrylic acid ester. CONSTITUTION:This base for a hair-dressing agent is produced by polymerizing a monomer component consisting of 60-95wt.% of (meth)acrylic acid monomer expressed by the formula I (R&lt;1&gt; is H or methyl) and 5-40wt.% of a (meth)acrylic acid ester monomer of the formula II (R&lt;2&gt; is H or methyl-; R&lt;3&gt; is 1-18C alkyl). The monomer component is preferably further incorporated with &lt;=35wt.% of an ethylenic unsaturated monomer (e.g. polypropylene glycol monoacrylate). The hair-dressing agent base is free from stickiness in use and gives smoothly and naturally collected hair. It is suitable for the use as hair-dressing agents such as set lotion, hair lotion, hair cream and hair mousse.
The invention relates to wine capable of strengthening health and prolonging life. The invention is characterized in that the wine comprises 15 kinds of traditional Chinese medicine such as ginseng, radix astragali, radix codonopsitis, polygonum, arillus longan, red jujube and lucid ganoderma and the wine is scientifically and delicately made by blending distillate spirits. The compounding is reasonable, the key points are emphasized and whole parts are given attention. Different components have different functions and the compounding is reasonable. The 15 kinds of traditional Chinese medicine of the invention have rich protein, fat, carbohydrate, vitamin A, vitamin B1, vitamin B2, vitamin C, vitamin D and 16 kinds of microelements such as autunite, phosphor, iron, iodine, selenium, manganese and strontium. The invention has the functions of delaying the senility of organism, adjusting the immunologic function, improving the metabolism of organism, improving the visceral function, supplying vitamin and microelements, strengthening health and prolonging life. The invention is the health wine capable of nourifying Qi, enriching the blood, activate &#39;Yin&#39;, activating &#39;Ying&#39; and prolonging life. Therefore, the invention is suitable for people who want to strengthen health and prolong life to drink in daily life.
PURPOSE:To provide a composition for dermal administration, containing a nicotinic acid ester, and effective to increase the transcutaneous permeability and absorptivity of the drug component. CONSTITUTION:The objective composition for dermal administration and effective to increase the transcutaneous absorptivity of a drug component can be produced by using the nicotinic acid ester of formula I (R is &gt;=5C alkyl) as an active component. The transcutaneous absorptivity of a drug can be improved further by using the compound of formula I in combination with a polar compound such as lower alcohol, glycerol, lactic acid, cyclic urea of formula II (R1-R2 are H or lower alkyl), etc. The amount of the compound of formula I is preferably 0.5-70wt% based on the sum of the polar compound and the compound of formula I. The present composition for dermal administration is preferably compound preliminarily with a drug (e.g. local anesthetic, antihistiaminic, antibiotic, etc.).
An optimal bicycle frame size based on operational characteristics provided by a rider when riding a dynamic fit unit is determined. A best-fit bicycle frame size that is a closest match to the optimal frame size is determined. At least one of the optimal X,Y location of the bicycle&#39;s handlebar relative to the bottom bracket, and the optimal X,Y location of the bicycle&#39;s seat relative to the bottom bracket, is determined. A stem and spacer from a list of available stems and spacers that will best fit between the head tube of the best-fit frame and the optimal X,Y location of the handlebar is determined. A seat post from a list of available seat posts that will best fit between the seat tube of the best-fit frame and the optimal X,Y location of the seat is determined. A list of the best-fit frame, the best fit stem and spacer, and the best fit seat post, is produced.
807,955. Artificial teeth. DENTISTS&#39; SUPPLY CO. OF NEW YORK. July 20, 1955 [Sept. 1, 1954], No. 21058/55. Class 81 (2). A porcelain artificial tooth is made by disposing raw porcelain dough around an anchorage made essentially of palladium which has been treated to render it substantially gas free, making the dough into a raw tooth biscuit having an opening extending to the anchorage, firing the biscuit to fuse the porcelain particles to each other and the anchorage while certain surfaces are exposed to the firing atmosphere, placing one end of a pin and solder into the opening in contact with the certain surfaces and subjecting the assembly to a temperature sufficient to decompose any palladium oxide and melt the solder to connect the pin and anchorage firmly together. The anchorage 12 which contains 86-100 per cent palladium is cup-shaped and is disposed on a moulding post secured to a mould which is charged with raw porcelain dough consisting of pulverized feldspar and organic binding agents. The mould, dough and anchorage are subjected to preliminary baking at 500-600 F. to produce a raw tooth biscuit. The moulding post is then removed and the raw tooth biscuit fired at a temperature of 2250-2300 F. which fuses the porcelain and produces a layer of palladium oxide on the exposed inner surface of the anchorage 12. A pin 22, made of nickel plated with gold or gold alloy, and fluxed silver solder 24 are then introduced into the anchorage 12, the assembly being then subjected to a temperature of 1450  F. which decomposes the palladium oxide and effects a firm soldered joint. Small quantities of silver, gold, platinum, indium, rhodium or ruthenium or alloys thereof may be alloyed with the palladium. The palladium or palladium alloy used is previously process-annealed in a gaseous atmosphere to render it gas free.
PURPOSE: To obtain the subject composition comprising elemental iodine, organic substance reactive to iodine, and a specified amount of iodate ion source, suppressed in the elemental iodine&#39;s loss and reduced in irritancy. CONSTITUTION: This composition is obtained by incorporating such an amount of an iodate ion source (e.g. sodium iodate, potassium iodate) as to be enough to afford 0.01-0.04wt.% of iodate, ion in a medicinal composition comprising an aqueous solution containing elemental iodine, an organic substance reactive to iodine (e.g. an aqueous solvent, iodine-solubilizing agent, iodine-complexing polymer such as polyvinylpyrrolidone) and a surfactant. The content of the elemental iodine in this composition is pref. 0.1-1.4 (esp. 0.75-1.25)wt.%, and the pH range for the composition is pref. pH3-7 (esp. pH4-6).
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a skin cosmetic for pimple with high safety, effective for prophylaxis and amelioration of pimples.  &lt;P&gt;SOLUTION: The invention relates to the skin cosmetic for pimple comprising (1) following (A), (B) and (C) as essential components. (A) is a lipases inhibitor, (B) is an androgen receptor-binding inhibitor, (C) is an antibacterial agent for Propionibacterium acnes, wherein the (A) the lipases inhibitor comprises one or two or more selected from Bergenia ligulata (Wall.) Eng extract, Eugenia javanica Lam., Eugenia javanica Lam. extract, Betula platyphylla var. japonica extract, Moutan Cortex extract, Creeping saxifrage extract, coix seed extract and Hamamelis virginiana, and the (B) the androgen receptor-binding inhibitor comprises one or two or more selected from cactus extract, Glycine max extract, Bergenia ligulata (Wall.) Eng extract, asiasari radix extract, Betula platyphylla var. japonica extract and Sanguisorba officinalis Linne extract, and the (C) the antibacterial agent for Propionibacterium acnes comprises one or two of Salix alba L extract and Olea europaea leaf extract.  &lt;P&gt;COPYRIGHT: (C)2006,JPO&amp;NCIPI
The invention belongs to the technical field of an aerogel material and discloses a powdery carbon aerogel, as well as a preparation method and an application thereof. The powdery carbon aerogel is formed by carbon nanometer ball building units with a grain size of 20-300 nm by cross-linking and stacking; lots of micropores are formed on the surface of the carbon nanometer balls, and the specific surface area is 294-2472 m&lt;2&gt;/g. The powdery carbon aerogel disclosed by the invention is micron-level powder, can be directly used without being ball-milled in lots of application fields, and contributes to simplification of an application technique. The powdery carbon aerogel disclosed by the invention has a high specific surface area which is as high as 2472m&lt;2&gt;/g at most, and has wide potential application in preparation of electrode materials, medicine release control materials and adsorbing materials. Moreover, the building unit of the powdery carbon aerogel has good sphericity degree and grain size uniformity, and is benefit for precise building of a nanometer structure. The preparation method of the powdery carbon aerogel is simple, realizes moderate and easily controlled reaction condition, and is beneficial to industrialization amplification.
The invention provides a foot bath formula for treating insomnia. The foot bath is prepared from, by weight, ramulus uncariae cum uncis, stems of miscanthus floridulus(Labill.)Warb., leaves of melia azedarach L., roots of pterospermum heterophyllum Hance., herba pyrolae, rhizoma pinelliae preparatum, raw dragon&#39;s teeth, fresh rhizoma imperatae, caulis bambusae in taenia, radix rhapontici, indigo naturalis, fructus viticis, herba taxilli, herba artemisiae scopariae, valerian roots, herba lophatheri, rhizoma acori tatarinowii, concha margaritifera, herba siegesbeckiae, herb of swertia punicea Hemsl. and folium artemisiae argyi water. According to the foot bath formula, ramulus uncariae cum uncis, stems of miscanthus floridulus(Labill.)Warb., leaves of melia azedarach L., roots of pterospermum heterophyllum Hance., herba pyrolae, rhizoma pinelliae preparatum and raw dragon&#39;s teeth serve as the main raw materials, fresh rhizoma imperatae, caulis bambusae in taenia, radix rhapontici, indigo naturalis, fructus viticis, herba taxilli, herba artemisiae scopariae, valerian roots, herba lophatheri, rhizoma acori tatarinowii, concha margaritifera, herba siegesbeckiae and herb of swertia punicea Hemsl. are added by taking the folium artemisiae argyi water as the basis, and therefore the foot bath has the function of dredging and activating collaterals, effectively improves sleep, promotes metabolism, increases blood circulation and strengthens the basic physical fitness of human bodies.
Formulations of highly diluted genetic material are disclosed. The genetic material may be human genetic material that is associated with a health effect in humans. For example, the genetic material may cause, ameliorate, reduce, or otherwise affect any form of illness, disease, and/or overall wellness in humans. The formulations are made by serially diluting an initial mixture that includes the genetic material. In one embodiment, a patient&#39;s genetic material is tested and the results are used to prepare a formulation specifically for the genetic predispositions and/or indicators exhibited by the patient. The formulations include homeopathic remedies.